Don’t Let COVID-19 Derail Your R&D Funding

One major part of funding R&D with grant or non-dilutive funding is understanding the timeline for this sort of funding. While academic researchers can be accustomed to the slow pace of the process, it can feel glacial for startups accustomed to moving at the speed of pharma. But there’s no denying this: the benefit of non-dilutive funding can definitely outweigh the advance planning required to make it happen. Continue reading “Don’t Let COVID-19 Derail Your R&D Funding”